Stay updated on LN-145 in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the LN-145 in Solid Tumors Clinical Trial page.

Latest updates to the LN-145 in Solid Tumors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedSite-wide revision updated from v3.4.1 to v3.4.2; no changes to study data or patient-facing content are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check23 days agoChange DetectedThe page now shows Revision: v3.4.1, with Revision: v3.4.0 no longer displayed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check30 days agoChange DetectedThe page adds a glossary toggle and updates metadata to Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0, replacing the previous lowercase wording Last Update Submitted that met QC Criteria and No FEAR Act data, as well as Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check44 days agoChange DetectedFooter revision updated from v3.3.3 to v3.3.4. No study content or functionality is altered.SummaryDifference0.0%

- Check66 days agoChange DetectedAdded a Locations section showing Texas (Houston, TX) as a study site. Updated the page to revision v3.3.3; removed the old Texas Locations label and the HHS Vulnerability Disclosure link.SummaryDifference0.2%

- Check94 days agoChange DetectedPage metadata updated to revision 3.3.2 and Last Update Posted (Estimated) timestamps. The core study content and eligibility criteria remain unchanged.SummaryDifference0.2%

Stay in the know with updates to LN-145 in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LN-145 in Solid Tumors Clinical Trial page.